Drug Shortage Report for PROCTOSEDYL
Report ID | 100518 |
Drug Identification Number | 02223252 |
Brand name | PROCTOSEDYL |
Common or Proper name | Hydrocortisone, Framycetin, Cinchocaine, Aesculin |
Company Name | APTALIS PHARMA CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | HYDROCORTISONE FRAMYCETIN SULFATE DIBUCAINE HYDROCHLORIDE ESCULIN |
Strength(s) | 5MG 10MG 5MG 10MG |
Dosage form(s) | OINTMENT |
Route of administration | RECTAL |
Packaging size | 30g |
ATC code | C05AA |
ATC description | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-12-06 |
Estimated end date | 2019-12-20 |
Actual end date | 2019-12-24 |
Shortage status | Resolved |
Updated date | 2019-12-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Company contact information; Telephone number: 800-668-6424 Email address: MR-GENERAL_INQUIRY@allergan.com Website address: allergan.ca Postal address: 500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2019-12-25 | English | Compare |
v4 | 2019-12-24 | French | Compare |
v3 | 2019-12-24 | English | Compare |
v2 | 2019-12-07 | French | Compare |
v1 | 2019-12-07 | English | Compare |
Showing 1 to 5 of 5